GB2337200A - Smoking substance for use in therapy by inhalation, based on a mixture of at least five medicinal herbs, ginkgo leaves as base & starch syrup/glycerin binders - Google Patents
Smoking substance for use in therapy by inhalation, based on a mixture of at least five medicinal herbs, ginkgo leaves as base & starch syrup/glycerin binders Download PDFInfo
- Publication number
- GB2337200A GB2337200A GB9810054A GB9810054A GB2337200A GB 2337200 A GB2337200 A GB 2337200A GB 9810054 A GB9810054 A GB 9810054A GB 9810054 A GB9810054 A GB 9810054A GB 2337200 A GB2337200 A GB 2337200A
- Authority
- GB
- United Kingdom
- Prior art keywords
- weight
- max
- pharmaceutically effective
- kitag
- binders
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000000391 smoking effect Effects 0.000 title claims abstract description 30
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 title claims abstract description 28
- 239000000126 substance Substances 0.000 title claims abstract description 24
- 235000011201 Ginkgo Nutrition 0.000 title claims abstract description 22
- 235000008100 Ginkgo biloba Nutrition 0.000 title claims abstract description 22
- 235000008216 herbs Nutrition 0.000 title claims abstract description 16
- 229920002472 Starch Polymers 0.000 title claims abstract description 15
- 235000019698 starch Nutrition 0.000 title claims abstract description 15
- 239000008107 starch Substances 0.000 title claims abstract description 15
- 235000011187 glycerol Nutrition 0.000 title claims abstract description 14
- 235000020357 syrup Nutrition 0.000 title claims abstract description 14
- 239000006188 syrup Substances 0.000 title claims abstract description 14
- 238000002560 therapeutic procedure Methods 0.000 title claims abstract description 14
- 239000011230 binding agent Substances 0.000 title claims abstract description 9
- 239000000203 mixture Substances 0.000 title description 17
- 241000218628 Ginkgo Species 0.000 title description 15
- 201000010099 disease Diseases 0.000 claims abstract description 25
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 25
- 239000000843 powder Substances 0.000 claims abstract description 15
- 240000000249 Morus alba Species 0.000 claims abstract description 14
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 14
- 241001063197 Ostericum grosseserratum Species 0.000 claims abstract description 14
- 241001080798 Polygala tenuifolia Species 0.000 claims abstract description 12
- 240000000031 Achyranthes bidentata Species 0.000 claims abstract description 11
- 241000317412 Arisaema amurense Species 0.000 claims abstract description 11
- 240000001659 Oldenlandia diffusa Species 0.000 claims abstract description 11
- 241001180873 Saposhnikovia divaricata Species 0.000 claims abstract description 11
- 241000123725 Sophora tonkinensis Species 0.000 claims abstract description 11
- 244000167222 Acanthopanax sessiliflorus Species 0.000 claims abstract description 10
- 235000017615 Acanthopanax sessiliflorus Nutrition 0.000 claims abstract description 10
- 244000001632 Acorus gramineus Species 0.000 claims abstract description 10
- 235000013073 Acorus gramineus Nutrition 0.000 claims abstract description 10
- 241000213006 Angelica dahurica Species 0.000 claims abstract description 10
- 241000601151 Clematis florida Species 0.000 claims abstract description 10
- 241000723369 Cocculus trilobus Species 0.000 claims abstract description 10
- 244000164480 Curcuma aromatica Species 0.000 claims abstract description 10
- 235000003398 Curcuma aromatica Nutrition 0.000 claims abstract description 10
- 241000305491 Gastrodia elata Species 0.000 claims abstract description 10
- 241000967218 Selaginella tamariscina Species 0.000 claims abstract description 10
- 240000000038 Ziziphus mauritiana Species 0.000 claims abstract description 10
- 235000006545 Ziziphus mauritiana Nutrition 0.000 claims abstract description 10
- 235000008529 Ziziphus vulgaris Nutrition 0.000 claims abstract description 10
- 244000024251 Aralia cordata Species 0.000 claims abstract description 9
- 235000014722 Aralia cordata Nutrition 0.000 claims abstract description 9
- 241000989077 Vitex rotundifolia Species 0.000 claims abstract description 9
- 244000237330 gutta percha tree Species 0.000 claims abstract description 9
- 241001347459 Prunella vulgaris var. lilacina Species 0.000 claims abstract description 8
- 240000006023 Trichosanthes kirilowii Species 0.000 claims abstract description 8
- 235000009818 Trichosanthes kirilowii Nutrition 0.000 claims abstract description 8
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 7
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 7
- 244000194101 Ginkgo biloba Species 0.000 claims abstract 7
- 235000019505 tobacco product Nutrition 0.000 claims description 18
- 210000003928 nasal cavity Anatomy 0.000 claims description 8
- 208000004296 neuralgia Diseases 0.000 claims description 8
- 239000004615 ingredient Substances 0.000 claims description 7
- 206010003246 arthritis Diseases 0.000 claims description 6
- 206010020772 Hypertension Diseases 0.000 claims description 5
- 244000223014 Syzygium aromaticum Species 0.000 claims description 5
- 235000016639 Syzygium aromaticum Nutrition 0.000 claims description 5
- 208000000112 Myalgia Diseases 0.000 claims description 4
- 206010012601 diabetes mellitus Diseases 0.000 claims description 4
- 206010028391 Musculoskeletal Pain Diseases 0.000 claims description 3
- 206010028980 Neoplasm Diseases 0.000 claims description 3
- 208000007613 Shoulder Pain Diseases 0.000 claims description 3
- 241000218989 Trichosanthes Species 0.000 claims description 3
- 208000014644 Brain disease Diseases 0.000 claims description 2
- 241000411851 herbal medicine Species 0.000 description 16
- 206010033799 Paralysis Diseases 0.000 description 12
- 239000003814 drug Substances 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 229940079593 drug Drugs 0.000 description 10
- 231100000869 headache Toxicity 0.000 description 10
- 206010019233 Headaches Diseases 0.000 description 9
- 239000000779 smoke Substances 0.000 description 9
- 208000002193 Pain Diseases 0.000 description 8
- 230000036407 pain Effects 0.000 description 8
- 230000001225 therapeutic effect Effects 0.000 description 7
- 206010061218 Inflammation Diseases 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 208000021090 palsy Diseases 0.000 description 6
- 230000001629 suppression Effects 0.000 description 5
- 208000024827 Alzheimer disease Diseases 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 244000179560 Prunella vulgaris Species 0.000 description 4
- 206010039966 Senile dementia Diseases 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 208000008035 Back Pain Diseases 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 208000008930 Low Back Pain Diseases 0.000 description 3
- 235000019506 cigar Nutrition 0.000 description 3
- 235000019504 cigarettes Nutrition 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 230000007721 medicinal effect Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- WLYGSPLCNKYESI-RSUQVHIMSA-N Carthamin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@@]1(O)C(O)=C(C(=O)\C=C\C=2C=CC(O)=CC=2)C(=O)C(\C=C\2C([C@](O)([C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(O)=C(C(=O)\C=C\C=3C=CC(O)=CC=3)C/2=O)=O)=C1O WLYGSPLCNKYESI-RSUQVHIMSA-N 0.000 description 2
- 241000208809 Carthamus Species 0.000 description 2
- KXXZLMLLYMPYJE-UHFFFAOYSA-N Cyperine Chemical compound OC1=CC(OC)=CC(C)=C1OC1=CC(C)=CC(O)=C1 KXXZLMLLYMPYJE-UHFFFAOYSA-N 0.000 description 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 2
- 241000208125 Nicotiana Species 0.000 description 2
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 208000014951 hematologic disease Diseases 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 201000005202 lung cancer Diseases 0.000 description 2
- 208000020816 lung neoplasm Diseases 0.000 description 2
- 210000001331 nose Anatomy 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 241000209495 Acorus Species 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 241000218158 Clematis Species 0.000 description 1
- 241000723370 Cocculus Species 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 241000219104 Cucurbitaceae Species 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 244000299452 Gouania lupuloides Species 0.000 description 1
- 235000000292 Gouania lupuloides Nutrition 0.000 description 1
- 208000027109 Headache disease Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 235000010674 Prunella vulgaris Nutrition 0.000 description 1
- 241001505096 Rhamnus davurica Species 0.000 description 1
- 241001107098 Rubiaceae Species 0.000 description 1
- 241000195974 Selaginella Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 231100000354 acute hepatitis Toxicity 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000000410 anti-febrile effect Effects 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 230000001663 anti-spastic effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- VJKUPQSHOVKBCO-RYVYVXLVSA-N cocculus solid Chemical compound O([C@@H]1C[C@]2(O)[C@@]34C)C14C(=O)O[C@@H]3[C@@H]1[C@H](C(=C)C)[C@H]2C(=O)O1.O([C@@H]1C[C@]2(O)[C@@]34C)C14C(=O)O[C@@H]3[C@@H]1[C@H](C(C)(O)C)[C@H]2C(=O)O1 VJKUPQSHOVKBCO-RYVYVXLVSA-N 0.000 description 1
- 210000000795 conjunctiva Anatomy 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 201000003265 lymphadenitis Diseases 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000006993 memory improvement Effects 0.000 description 1
- 231100000544 menstrual irregularity Toxicity 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 230000004526 pharmaceutical effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Emergency Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Otolaryngology (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Reproductive Health (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
Abstract
A smoking substance is provided for use in disease therapy, which is prepared from pharmaceutically effective herb powders and binders, the pharmaceutically effective herb powder comprising ginkgo leaves as a base component and at least five herbs selected from the group consisting of: Polygala tenuifolia Willdenow, Acorus gramineus SOLAND., Vitex rotundifolia L., Angelica koreana Maximowicz, Ziziphus jujuba Miller, Curcuma aromatica SALISB., Clematis florida THUNB., Acanthopanax sessiliflorus SEEM., Aralia cordata THUNB., Achyranthes bidentata BL., Cocculus trilobus DC., Morus alba L., Oldenlandia diffusa ROXB., Sophora subprostrata CHUN., Arisaema amurense Max var. Serratum Nakai, Selaginella tamariscina SPRING., Prunella vulgaris var. lilacina NAKAI., Trichosanthes kirilowii MAX., Ledebouriella divaricata UEKI., Lingusticum tenuissimum KITAG., Angelica dahurica BENTH., Gastrodia elata BL., Eucommia ulmoides OLIVER., Carthamus tinctorius L., and Schizonepete tenuifolia KITAG.; and the binders comprising starch syrup and glycerin.
Description
2337200 SMOKING SUBSTANCE FOR USE IN THERAPY BACKGROUND OF THE INVENTION
is - 25
Field of the invention -
The present invention relates to a smoking substance for use in disease therapy and to a therapy method utilizing the same. More particularly, the present invention is concerned with an herbal medicine which is inhalable through smoking, as in tobacco products, such that its medicinal effective ingredients can be taken into the bod.)7 by inhalation through the nasal cavity, to treat various diseases occurring within the body and with a therapy method utilizing the same.
Description of the Prior Art
In most cases of treating various diseases, surgical therapy and drug therapy are used, alone or in combination. For the application of drugs, techniques for internal use and external use are developed. In external use, for example, a certain drug paste -Js directly applied to or coated on affected parts. However, when the affected parts are within the body or diseases occur in the internal organs, such drugs are impossible to directly apply to the troubled parts.
In traditional Chinese medical science, internal 1 1 4 1 f medicines are administrated to treat diseases in many cases. If necessary, the internal medicines are used, together with medicines for external use, to enhance the therapeutic effect. However, modern persons may be reluctant to eat the herbal medicines due to their characteristic taste.
Today, herbal medicines, if once prepared, can be conveniently stored for long periods of time by use of modern apparatuses. In addition, the herbal medicines can be administrated to desired body parts conveniently, and advantageously mass-produced, nowadays.
Nevertheless, internal herbal medicines are frequently refused use. Following are the reasons why internal herbal medicines may not be welcomed. Because internal herbal medicines are usually prescribed to be administrated at regular intervals, persons need to carry the herbal medicines with them. However, although various internal herbal medicines are developed, most of them are inconvenient to carry. occasionally, there occur such cases where it is of embarrassment for persons to apply herbal medicines to oneself at places other than private sites, such as at home.
As an example of the internal use of herbal medicine, there is an inhalation treatment through the nasal cavity. For example, the smoke which results f rom the burning of medicinal herbs is inhaled through the 'nasal cavity. This inhalation treatment is handed down fiom generation to 2 generation. Oriental ancient medical documents disclose that the inhalation treatment' can be applied for various diseases. The inhalation treatment, however, is disadvantageous in several aspects. First, the intake of the medicinal smoke is achieved along with the inhalation of one's breath. Because the smoke source is positioned. at a distance from the nose, the smoke is dispersed in the air and enters not only the nose but also the eyes. In this case, one may shed tears and the smoke irritates the conjunctiva and the cornea of the eyes, causing a side effect of inflammation. In addition, if the inhalation is carried out at open places wherein the wind rises, the intake of the smoke through the nasal cavity is difficult.
Thus far, there has been not yet, to the inventor's knowledge, developed an inhalation treatment through the mouth.
SUMMARY OF THE INVENTION
Therefore, it is an object of the present invention to overcome the above problems encountered in prior arts and to p7ovide an inhalation treatment in which therapeutically effective smoke is inhaled through the mouth to treat various diseases.
It is another object of the present invention to provide 3 f.
1 1 i 1 an herbal medicine which is convenient to carry and can be applied irrespective of where one may be.
It is a further object of the present invention to provide a smoking substance for use in disease therapy, which gives therapeutically effective smoke to the smokers.
In accordance with the present invention, there is provided a smoking substance for use in disease therapy, which is prepared from pharmaceutically effective herb powders and binders, the pharmaceutically effective herb powder comprising ginkgo leaves as a base component and at least five herbs selected from the group consisting of Polygala tenuifolia Willdenow, Acorus gramineus SOLAND., Vitex rotundifolia L., Angelica koreana Maximowicz, Ziziphus jujuba Miller, Curcuma aromatica SALISB., Clematis florida THUNB., Acanthopanax sessiliflorus SEEM., Aralla cordata THUNB., Achyranthes bidentata BL., Cocculus trilobus DC., Morus alba L., Oldenlandia diffusa ROXB., Sophora subprostrata CHUN., Arisaema amurense Max var. Serratum Nakai, Selaginella tamariscina SPRING. , Prunella vulgarls var. lilacina NAKAI., Trichosanthes kirilowii MAX., Ledebouriella divaricata UEKI., Lingusticum tenuissimum KITAG., Angelica dahurica BENTH., Gastrodia elata BL., Eucommia ulmoides OLIVER., Carthamus tinctorlus L., and Schizonepete tenuifolia KITAG., the binders comprising about 1-10 % by weight of starch syrup and about 0. 1-1 % by weight of glycerin based on the total weight of the 4 herb powder, and which is inhalable through smoking, as in tobacco products, with a moisture content of 1213 %, whereby pharmaceutical effective ingredients are taken into the body by inhalation through the nasal cavity.
BRIEF DESCRIPTION OF THE DRAWING
Fig. 1 is a flow chart showing the processes of producing a smoking substance for use in disease therapy.
DETAILED DESCRIPTION OF THE INVENTION
The smoking substance according to the present invention is prepared from the medicinal herbs comprising ginkgo leaves as a base component and at least five herbs selected from the group consisting of Polygala tenuifolia Willdenow, Acorus gramineus SOLAND., Vitex rotundifolia L., Angelica koreana Maximow.fcz, Ziziphus jujuba Miller, Curcuma aromatica SALISB., Clematis florida THUNB., Acanthopanax sessiliflorus SEEM., Aralia cordata THUNB., Achyranthes bidentata BL., Cocculus tr.tilobus DC., Morus alba L., Oldenlandia diffusa ROXB., Sophora subprostrata CHUN., Arisaema amurense Max, var. Serratum Nakai, Selaginella tamariscina SPRING., Prunella vulgaris var. lilacina NAKAI., Trichosanthes kiril-owii MAX., Ledebouriella divaricata UEKI., Lingusticum tenuissimum KITAG., Angelica dahurica BENTH., Gastrodia elata BL., Eucommia ulmoides OLIVER., Carthamus tinctorius L., and Schizonepete tenuifolia KITAG. These medicinal herbs are mixed with about 1-10 % by weight of starch syrup and about 0.1-1 % by weight of glycerin and formed into, for example, a cigarette or cigar with the moisture content of about 12-13 %.
The term "smoking substance" as used herein means all tobacco forms, such as cigars, cigarettes and tobacco pouches, which contain the pharmaceutically effective herbal mixture of the present invention.
Ginkgo leaves contain various flavonoids and are found to be effective for the treatment of blood diseases and show anti-inflammation activity, neuralgia relief and anticarcinogenesis.
Arisaema amurense Max var. Serratum Nakal, a perennial herb, contains saponin, cyperine, benzoic acid and starch in large quantities and is effective for cough remedies, discharge of phlegm, asthma, paralysis, lung cancer, headache, emesis, hypertension, senile dementia, neuralgia, and myalgia.
Angelica koreana Maximowicz, a perennial herb belonging to a family of Umbelliferea, is known to be effective for paralysis, hemiplegia, neuralgia, arthritis and headache.
Eugenia caryophyllata Thunberg is high in herbal medicine warm element properties and harmless so that its dried clove bud is effective for dyspepsia, feeble appetite and gastritis.
is 6 Zjziphus jujuba Miller is a seed of the Dahurian buckthorn, showing a medicinal effect for sleeplessness, nervous breakdown, headache and heart disease.
As for Polygala tenuifolia Willdenow, it is a root of Polygala tenuifolia or P. sibiricva which is recorded in ancient oriental documents to show a high clinical effect for headache, senile dementia, memory enhancement, heart disease, nerve sedateness and sleeplessness.
Of the whole body of Acorus gramineus SOLAND. the pharmaceutically effective part is its main root which is harvested in the fall and dried in the sun. The root is washed and cut into a size of 10 cm before the drying. Its medicinal effects include palsy prevention, energy circulation, blood circulation and discharge of phlegm.
Vitex rotundifolia L. brings forth seeds which are used to treat cough, convulsion and headache.
The herb Curcuma aromatica SALISB., which is low in herbal medicine warm element properties and pungent, is dried and powdered for use. It is prescribed against blood clot, energy unbalance, venereal disease, hematuria, inflammation, an heartache.
As for Clematis florida THUNB., belonging to a family of Rannculaceae, its root is effective for pain relief, palsy suppression, and circulation.
Acanthopanax sessiliflorus SEEM.'s root shows good 7 t therapeutic activity for palsy suppression and blood circulation.
Aralia cordata THUNB. a perennial herb, grows to a height of 1-1. 5 m. Its thick rootstock is spread out in side directions and circumferential white roots extend to a long distance from the rootstock. These rootstock and roots show therapeutic efficacy in diaphoresis, pain relief, diuresis, and palsy suppression, so that they are added in the herbal medicine composition prescribed against cough, neuralgia, arthritis and rheumatism.
Achyranthes bidentata BL., a perennial herb, grows straightly to a height of 40-90 cm and two opposite branches are spread out of one node on its stalk. Its root shows pharmaceutical effects including diuresis, pain relief and anti-inflammation.
The leaves of Cocculus trilobus DC. are of polygonal shield shape and slightly split into 3-9 parts. These leaves are known to be efficacious against myalgia and inflammation and for pain,relief.
The leaves of Morus alba L. are prescribed for the treatment of hypertension, bronchial asthma, pneumonia, lung cancer, diabetes and for the discharge of phlegm and the reduction of cholesterol level.
Oldenlandia diffusa ROXB., an annual herb belonging to a family of Rubiaceae, grows to a size of 10-30 cm with white 8 thin roots extending circumferentially. Its stalk is prostrate and has many branches and its leaves are endpointed. Showing pharmaceutical activities in fever alleviation, antiphlogistic action, anti-inflammation, urination, blood circulation, and pain relief, this herb is prescribed against hepatitis, tonsillitis, lumbago and sore throat.
The useful part of Sophora subprostrata CHUN. in the present invention is the root. Its mithridatizing activity is usually used to treat the swollen sore throat.
Selaginella tamariscina SPRING. is recorded to be effective in treating blood diseases, such as menstrual irregularity, blood discharging, and anaemia.
Prunella vulgarls var. lilacina MAKAI., a perennial herb belonging to a family of Labiatae, grows to a size of about 30 cm with a rectangular, hairy stalk. Because it shows the medicinal activities of removing liver poison, antiinflammation, and removing clot, the stalk of Prunella vulgaris var.. lilacina NAKAI. is used to treat lymphadenitis, tuberculosis, mastitis, wen, breast cancer, eye diseases, dizziness, acute hepatitis, acute paralysi s, uterine hiemorrhage, and leucorrhea.
Trichosanthes kirilowii MAX. a perennial herb belonging to a family of Cucurbitaceae, has leaves which are crisscross and split into a hand form. Tendrils spread out of the 9 f i armpits of the leaves. Its roots are prescribed as a disfectant, an antifebrile and a phlegm discharger.
Ledebouriella divaricata UEKI., belonging to a family of Umbelliferae, has pharmaceutically useful roots. With medicinal effects of perspiration, poison neutralization, palsy suppression, edema removal and pain relief, the roots are used to treat cold, C.V.A., neuralgia, arthritis, etc.
Lingusticum tenuissimum KITAG., a perennial herb, emits a fragrance and is used as an analgesic and an antispastics for relieving the headache resulting from a cold and the lumbago. This herb can be used as an medicine for external use.
Like Lingusticum tenuissimum KITAG., Angelica dahurica.BENTH.1s root is prescribed against headache and lumbago and can be used as an medicine for external use.
Gastrodia elata BL. is hot in taste and slightly high in herbal me dicine warm element properties. Its root is used for the treatment of headache and dizziness.
Cartham.us tinctorjus L. is slightly high in herbal medicine warm element properties. Its seeds are useful for such as extravasated blood and blood circulation. and used as a pigment for food or cosmetics.
Showing the medicinal activities of perspiration, fever alleviation, palsy suppression, pain relief and stanching, Schizonepete tenuifolia KITAG., a herb belonging to a family blood control is of Liabiatae, is useful against chilling, fevering, paralysis, blood spitting, and rubella.
As mentioned above, the smoking substance for use in disease therapy, according to the present invention, comprises ginkgo leaves as an essential ingredient and at least five herbs selected from the herb group, depending on their medicinally effective activities against certain diseases.
For example, a smoking substance comprising about 20-30 % by weight of ginkgo leaves and about 5-13 % by weight of each of Polygala tenuifolia Willdenow, Acorus grainineus SOLAND., Vitex rotundifolia L., Angelica koreana Maximowicz, Ziziphus jujuba Miller, Curcuma aromatica SALISB., Lingusticurn tenu-issimum KITAG., Angelica dahurica BENTH., and Gastrodia elata BL. can be applied for brain diseases, such as paralysis, senile dementia, headache and dizziness and about 20-30 % by weight of ginkgo leaves, about 15-25 % by weight of Clematis florida THUNB. and about 5-12 % by weight of each of Eucommia ulmoides OLIVER., Carthamus tinctorius L., Acanthopanax sessiliflorus SEEM., Angelica koreana Maximowicz, Aralia cordata THUNB., Achyranthes bidentata BL., and Cocculus trilobus DC. for such diseases as neuralgia, arthritis, m1scular pain and shoulder pain. A smoking substance useful in cancer treatment comprises about 15-25 % by weight of each of ginkgo leaves, Oldenlandia diffusa ROXB. and Arisaema amurense Max var. Serratum Nakai, and about 5-15 % by weight 11 of each of Morus alba L., Sophora subprostrata CHUN., Selaginella tamarlscina SPRING., and Eugenia caryophyllata Thunberg. Another example of medicinal smoking substance comprises about 15-25 % by weight of each of ginkgo leaves, Morus alba L., Prunella vulgaris var. lilacina NARAI., and Ledebouriella divaricata UEKI., and about 15-25 % by weight of each of Trichosanthes kirilowii MAX. and Schizonepete tenuifolia KITAG. and is effective for the treatment of hypertension and diabetes.
The medicinal herbs used in the present invention are not particularly limited in their amounts but are preferably used at the amounts enough to perform their pharmaceutical functions. As for the formulation of the herbs, it is well known to those who are skilled in the art. Further, additional herbs other than are not mentioned above, can be added to the herb mixture of the present invention and this is also within the scope of the invention.
Referring to Fig. 1, there is a flow chart showing the processes of.producing a smoking substance for use in disease therapy.
As shown in Fig. 1, at least five herbs applicable for the treatment of certain diseases are selected from the group consisting of Polygala tenuifolia Willdenow, Acorus gramineus SOLAND., Vitex rotundifolia L., Angelica koreana Maximowicz, Ziziphus jujuba Miller, Curcuma aromatica SALISB., Clematis 4 12 florida THUNB., Acanthopanax sessiliflorus SEEM., Aralia cordata THUNB., Achyranthes bidentata BL., Cocculus trilobus DC., Morus alba L., Oldenlandia diffusa ROXB., Sophora subprostrata CHUN., Arisaema amurense Max var. Serratum Nakai, Selaginella tamariscina SPRING., Prunella vulgaris var. lilacina NAKAI., Trichosanthes.k-irilowii MAX., Ledebouriella divaricata UEKI., Lingusticum tenuissimum KITAG., Angelica dahurica BENTH., Gastrodia elata BL., Eucommia ulmoides OLIVER., Carthamus tinctorjus L., and Schizonepete tenulfolia KITAG., cut into a size of about 0. 5-1 mm along with ginkgo leaves and homogeneously mixed together. The resulting mixture is aged for 10-20 days in a closed container while keeping its moisture content at 18-21%. After being colddried to a moisture content of 13-14 %, the herb mixture is added with about 1-10 wt% of starch syrup and about 0.1-1 wt% of glycerin on the basis of the weight of the herb mixture. Thereafter, this mixture is adjusted to have a moisture content of 12-13% and then, made into a form of, for example, cigars or cigarettes.
With the aim of facilitating the aggregation of the herb copponents and improving the flavor of the tobacco-like products, starch syrup and glycerin are preferably added within the above-mentioned range. For example, if they are used too little, the flavor effect is poor. On the other hand, if they are added in excess, it takes a long time to dry f them, so that it is economically unfavorable. In addition, excess starch syrup and glycerin result in an over- aggrega t ion of the herb components, which requires an additional pulverization process.
As mentioned, the smoking. substance of the present invention is inhalable through smoking, as in tobacco products, at regular intervals, such that its medicinal effective ingredients can be taken into the body by inhalation through the nasal cavity, to treat various diseases occurring within the body.
A better understanding of the present invention may be obtained through the following example which is set forth to illustrate, but is not to be construed as the limit of the present invention.
i EXAMPLE I g of ginkgo leaves, 10 g of Poly-gala tenuifolia Willdenow, 10 g of Acorus gramineus SOLAND., 10 g of Lingusticum tenuissimum KITAG., 10 g of Angelica dahurica BENTH., 10 g of Gastrodia elata BL., 10 g of Vi tex rotundifolia L., 10 g of Angelica koreana Maximowicz, 10 g of Ziziphus jujuba Miller, and 10 g of Curcuma aromatica SALISB., were mixed well together and aged for 15 days in a closed container while keeping its moisture content at 18-21%. After 14 being cold-dried to a moisture content of 1314 %, the herb mixture was added with about 50 g of starch syrup and about 5 g of glycerin. Thereafter, this mixture was adjusted to have a moisture content of 12- 13% and then, made into tobacco products. These tobacco products were smoked by 100 persons suffering from paralysis, senile dementia, headache or dizziness. The tobacco products were found to have good therapeutic effects on these diseases and showed synergy effects in combination with other internal medicines.
is EXAMPLE II g of ginkgo leaves, 20 g of Clematis florida THUNB., 10 g of Eucommia ulmoides OLIVER., 10 g of Carthamus tinctorius L., 10 g of Acanthopanax sessiliflorus SEEM., 10 g of Angelica koreana Maximowicz, 10 g of Aralia cordata THUNB., 10 g of Achyranthes bidentata BL., and 10 g of Cocculus trilobus DC. were mixed well together and aged for 15 days in a closed container while keeping its moisture content at 1821%. After being cold- dried to a moisture content of 13-14 %, the herb mixture was added with about 50 g of starch syrup and about 5 g of glycerin. Thereafter, this mixture was adjusted to have a moisture content of 12-13% and then, made into tobacco products. These tobacco products were smoked by 100 persons suffering from neuralgia, arthritis, muscular pain or 1 b shoulder pain. The tobacco products were found to have good therapeutic effects on these diseases and showed synergy effects in combination with other internal medicines.
EXAMPLE III g of ginkgo leaves, 10 g of Morus alba L., 20 g of Oldenlandia diffusa ROXB., 10 g of Sophora subprostrata CHUN., 20 g of Arisaema amurense Max var. Serratum Nakal, 10 g of Selaginella tamariscina SPRING., and 10 g of Eugenia caryophyllata Thunberg were mixed well together and aged for 15 days in a closed container while keeping its moisture content at 1821%. After being cold-dried to a moisture content of 13-14 %, the herb mixture was added with about 50 g of starch syrup and about 5 g of glycerin. Thereafter, this mixture was adjusted to have a moisture content of 12- 13% and then, made into tobacco products. These tobacco products were smoked by 100 persons suffering from various cancers. The tobacco products were found to have good therapeutic effects on these diseases and showed synergy effects in combination with other internal medicines.
EXAMPLE IV g of ginkgo leaves, 20 g of Morus alba L., 16 g of Prunella vulgarls var. lilacina NAKAI., 10 g of Trichosanthes kirilowii MAX., 20 g of Ledebouriella divaricata UEKI., and 20 g of Schizonepete tenuifolia KITAG. were mixed well together and aged for 15 days in a closed container while keeping its moisture content at 18-21%. After being cold-dried to a moisture content of 13-14 %, the herb mixture was added with about 50 g of starch syrup and about 5 g of glycerin. Thereafter, this mixture was adjusted to have a moisture content of 12- 13% and then, made into tobacco products. These tobacco products were smoked"by 100 persons suffering from hypertension or diabetes. The tobacco products were found to have good therapeutic effects on these diseases and showed synergy effects in combination with other internal medicines.
As described hereinbefore, the smoking substance in accordance with the present invention is prepared from the medicinal herbs comprising ginkgo leaves as a base component and at least five herbs selected from the group consisting of Polygala tenuifolia Willdenow, Acorus gramineus SOLAND., Vi tex ro,tundifolia L., Angelica koreana Max-imowicz, Ziziphus jujuba Miller, Curcuma aromatica SALISB., Clematis florida THUNB., Acanthopanaz sessiliflorus SEEM., Aralia cordata THUNB., Achyranthes bidentata BL., Cocculus trilobus DC., Morus alba L., Oldenlandia diffusa ROXB., Sophora subprostrata CHUN., 17 1 Arisaema amurense Max var. Serratum Nakai, Selaginella tamariscina SPRING. , Prunella vulgaris var. lilacina NAKAI., Trichosanthes kirilowi-i MAX., Ledebouriella divaricata UEKI., Lingusticum tenuissimum KITAG., Angelica dahurica BENTH., Gastrodia elata BL., Eucommia ulmoides OLIVER., Carthamus tinctorius L., and Schizonepete tenuifolia KITAG. in combination with about 110 % by weight of starch syrup and about 0.11 % by weight of glycerin. The smoking substance is in a form of tobacco product with a moisture content of 12-13 %, which is inhalable through smoking, such that its medicinal effective ingredients can be taken into the body by inhalation through the nasal cavity, to treat various diseases occurring within the body. This smoking substance is convenient to carry and can be applied irrespective of where one may be. In addition, it gives therapeutically effective smoke to the smokers.
The present invention has been described in an illustrative manner, and it is to be understood that the terminology. used is intended to be in the nature of description rather than of limitation. Many modifications and variations of the present invention are possible in. light of the above teachings. Therefore, it is to be understood that within the scope of the appended claims, the invention may be practiced otherwise than as specifically described.
18
Claims (6)
1. A smoking substance for use in disease therapy, which is prepared from pharmaceutically effective herb powders and binders, said pharmaceutically effective herb powder comprising ginkgo leaves as a base component and at least five herbs selected from the group consisting of Polygala tenuifolia Willdenow, Acorus gramineus SOLAND., Vitex rotundifolia L., Angelica koreana Maximowicz, Ziziphus jujuba Miller, Curcuma aromatica SALISB., Clematis florida THUNB., Acanthopanax sessiliflorus SEEM., Aralia cordata THUNB., Achyranthes bidentata BL., Cocculus trilobus DC., Morus alba L., Oldenlandia diffusa ROXB., Sophora subprostrata CHUN., Arisaema amurense Max var. Serratum Nakai, Selaginella tamariscina SPRING., Prunella vulgaris Var. lilacina MAKAI., Trichosanthes kirllowil MAX., Ledebouriella divaricata UEKI., Lingusticum tenuissimum KITAG., Angelica dahurica BENTH., Gastrodia elata BL., Eucommia ulmoides OLIVER., Carthamus tinctorius L., and Schizonepete tenuifolia KITAG., said binders comprising about 1-10 % by weight of starch syrup and about 0.1-1 % by weight of glycerin based on the total weight ot the herb powder, and which is inhalable through smoking, as in tobacco products, with a moisture content of 12-13 %, whereby pharmaceutical effective ingredients are taken into the body by inhalation through the nasal cavity.
19 9
2. A smoking substance in accordance with claim 1, which is used for the treatment of brain diseases, wherein said pharmaceutically effective herb powders comprise about 20-30 % by weight of ginkgo leaves and about 5-13 % by weight of each of Polygala tenuifolia Willdenow, Acorus gramineus SOLAND., Vitex rotundifolia L., Angelica koreana Max-imowicz, Ziziphus jujuba Miller, and Curcunza aromatica SALISB.
3. A smoking substance in accordance with claim 1, which is used for the treatment of neuralgia, arthritis, muscular pain and shoulder pain, wherein said pharmaceutically effective herb powders comprise about 20-30 % by weight of ginkgo leaves, about 15-25 % by weight of Clematis florida THUNB., and about 5-12 % by weight of each of Acanthopanax sessiliflorus SEEM., Angelica koreana Maximowic-, Aralia cordata THUNB., Achyranthes bidentata BL., and Cocculus trilobus DC.
4. A smoking substance in accordance with claim 1, which is used for the treatment of cancers, wherein said pharmaceutically effective herb powders comprise about 15-25 % by weight of each of ginkgo leaves, Oldenlandia diffusa ROXB. and Arisaema amurense Max var. Serratum Nakai, and about 5-15 % by weight of each of Morus alba L., Sophora subprostrata CHUN., Selaginella tamariscina SPRING., and Eugenia caryophyllata Thunberg.
5. A smoking substance in accordance with claim 1, which is used for the treatment of hypertension and diabetes, wherein said pharmaceutically effective herb powders comprise about 15-25 % by weight of each of ginkgo leaves, Morus alba L., Prunella vulgaris var. lilacina NAKAI., and Ledebouriella divaricata UEKI., and about 15-25 % by weight of each of Trichosanthes kirilowii MAX. and Schizonepete tenuifolia KITAG.
6. A smoking substance for use in disease therapy, which is prepared from pharmaceutically effective herb powders and binders, said pharmaceutically effective herb powder comprising ginkgo leaves as a base component and at least five herbs selected from the group consisting of Polygala tenuifolia Willdenow, Acorus gramineus SOLAND. Vitex rotundifolia L., Angelica koreana Maximowicz, Ziziphus jujuba Miller, CurCuma aromatica SALISB., Clematis florida THUNB., Acanthopanax sessiliflorus SEEM., Aralla cord ata THUND., Achyranthes bidentata BL., Cocculus trilobus DC., Morus alba L., Oldenlandia diffusa ROXB., Sophora subprostrata CHUN., Arisaema amurense Max var. Serratum Nakai, Selaginella tamariscina SPRING., Prunella vulgaris var. lilacina NARAI., Trichosanthes kirilowii MAX., Ledebouriella divaricata UEKI., Lingusticum tenuissimum KITAG., Angelica dahurica BENTH., 21 Gastrodia elata BL., Eucommia ulmoides OLIVER., Carthamus tinctorius L., and Schizonepete tenuifolia KITAG., said binders comprising about 1-10 % by weight of starch syrup and about 0. 1-1 % by weight of glycerin based on the total weight o' the herb powder, and which is inhalable through smoking, as in tobacco products, with a moisture content of 12-13 whereby pharmaceutical effective ingredients are taken into the body by inhalation through the mouth.
22
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10010304A JPH11209274A (en) | 1998-01-22 | 1998-01-22 | Smoking material for treating disease |
| GB9810054A GB2337200B (en) | 1998-01-22 | 1998-05-11 | Smoking substance for use in therapy |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10010304A JPH11209274A (en) | 1998-01-22 | 1998-01-22 | Smoking material for treating disease |
| GB9810054A GB2337200B (en) | 1998-01-22 | 1998-05-11 | Smoking substance for use in therapy |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| GB9810054D0 GB9810054D0 (en) | 1998-07-08 |
| GB2337200A true GB2337200A (en) | 1999-11-17 |
| GB2337200B GB2337200B (en) | 2000-07-26 |
Family
ID=26313644
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB9810054A Expired - Fee Related GB2337200B (en) | 1998-01-22 | 1998-05-11 | Smoking substance for use in therapy |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JPH11209274A (en) |
| GB (1) | GB2337200B (en) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20010001890A (en) * | 1999-06-09 | 2001-01-05 | 남기옥 | Method for making a smoking product with mugwort and eucommia ulmoides oliver |
| CA2378052C (en) * | 1999-08-12 | 2010-03-23 | Katy Drieu | Use of ginkgo extract |
| KR20030004562A (en) * | 2001-07-05 | 2003-01-15 | 정진남 | Cigarette |
| KR20010082484A (en) * | 2001-07-30 | 2001-08-30 | 이주훈 | Method of making cigarettes using herbage |
| EP1855702A2 (en) * | 2004-06-09 | 2007-11-21 | Shenzhen Qianrenren Sci. & Tech. Development Co. | Herbal compositions for prevention and treatment of rheumatic and inflammatory diseases and method of preparing the same |
| CN101878953B (en) * | 2010-07-22 | 2012-10-31 | 湖北中烟工业有限责任公司 | A kind of citron natural tobacco flavor additive and preparation method thereof |
| CN102349953B (en) * | 2011-10-19 | 2013-05-08 | 聂国祥 | Traditional Chinese medicine for treating chronic pharyngitis |
| CN102600431A (en) * | 2012-04-05 | 2012-07-25 | 杭州市中医院 | Ointment for activating blood and relieving pain, and preparation method thereof |
| CN102641357B (en) * | 2012-05-07 | 2013-08-21 | 孙志强 | Medicament for treating hypertension and preparation method thereof |
| CN102754911B (en) * | 2012-07-02 | 2015-01-21 | 广西中烟工业有限责任公司 | Harm reducing natural plant additive for cigarettes, and preparation method and application thereof |
| CN103055014B (en) * | 2012-12-31 | 2014-09-17 | 青岛华仁技术孵化器有限公司 | Folium ginkgo health product for preventing senile dementia and preparation method thereof |
| CN104248648A (en) * | 2013-06-28 | 2014-12-31 | 江苏天晟药业有限公司 | Method for extracting general flavones from Herba Selaginellae |
| CN104547653B (en) * | 2013-10-15 | 2018-04-17 | 宁云红 | A kind of Chinese prescription for treating chronic nasosinusitis |
| CN103653237A (en) * | 2013-11-05 | 2014-03-26 | 李文彩 | Health-care cigarette capable of reducing hypertension, hyperglycemia and hyperlipidemia |
| CN104524270A (en) * | 2014-12-17 | 2015-04-22 | 王华富 | Pills for relieving renal dysfunction caused by diabetes mellitus and preparation method thereof |
| CN104491805A (en) * | 2014-12-20 | 2015-04-08 | 长沙佰顺生物科技有限公司 | Traditional Chinese medicine preparation for treating Qi and blood stasis |
| CN104606468A (en) * | 2014-12-31 | 2015-05-13 | 姜晓明 | Traditional Chinese medicine formula for treating dizziness with syndrome of static blood blocking orifices and preparation method of traditional Chinese medicine formula |
| CN104706862A (en) * | 2015-02-12 | 2015-06-17 | 青岛静康医院 | Traditional Chinese medicine composition for treating rheumatic and rheumatoid bone diseases and preparation method of traditional Chinese medicine composition |
| CN104801276A (en) * | 2015-02-13 | 2015-07-29 | 云南中烟工业有限责任公司 | Gastrodia elata porous particle and applications thereof |
| CN105327274A (en) * | 2015-11-10 | 2016-02-17 | 孙绪连 | Traditional Chinese medicine decoction for treating Meniere disease |
| CN108117928A (en) * | 2016-11-30 | 2018-06-05 | 湖北中烟工业有限责任公司 | A kind of flavouring relax larynx tobacco aromaticss and application |
| CN106723272A (en) * | 2016-12-22 | 2017-05-31 | 安徽省农业科学院烟草研究所 | A kind of baking process of disease tobacco leaf |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB459942A (en) * | 1934-04-14 | 1937-01-15 | Gyula Boschan | Process for the manufacture of medicated smoking goods |
| GB605600A (en) * | 1945-11-12 | 1948-07-27 | Nils Artur Salomon Berg | Improvements in or relating to cigarettes filled with medicinal smoking mixture |
| US5229120A (en) * | 1992-02-05 | 1993-07-20 | Devincent James F | Treatment for cocaine abuse |
| JPH08266261A (en) * | 1995-03-30 | 1996-10-15 | Hideki Kamiya | Cigarette |
-
1998
- 1998-01-22 JP JP10010304A patent/JPH11209274A/en active Pending
- 1998-05-11 GB GB9810054A patent/GB2337200B/en not_active Expired - Fee Related
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB459942A (en) * | 1934-04-14 | 1937-01-15 | Gyula Boschan | Process for the manufacture of medicated smoking goods |
| GB605600A (en) * | 1945-11-12 | 1948-07-27 | Nils Artur Salomon Berg | Improvements in or relating to cigarettes filled with medicinal smoking mixture |
| US5229120A (en) * | 1992-02-05 | 1993-07-20 | Devincent James F | Treatment for cocaine abuse |
| JPH08266261A (en) * | 1995-03-30 | 1996-10-15 | Hideki Kamiya | Cigarette |
Non-Patent Citations (1)
| Title |
|---|
| WPI Abstract Accession No 96-512652/199651 & JP080266261 A [1996] * |
Also Published As
| Publication number | Publication date |
|---|---|
| GB9810054D0 (en) | 1998-07-08 |
| JPH11209274A (en) | 1999-08-03 |
| GB2337200B (en) | 2000-07-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2337200A (en) | Smoking substance for use in therapy by inhalation, based on a mixture of at least five medicinal herbs, ginkgo leaves as base & starch syrup/glycerin binders | |
| CN102266125B (en) | Health care type traditional Chinese medicine electronic cigarette for quitting smoking | |
| WO2021068464A1 (en) | Heat-not-burn vapor generating body and preparation method therefor, tobacco product and vapor generating body | |
| US5992421A (en) | Alternate cigarette and method for preparing the same | |
| WO2002047494A1 (en) | Cigarette with chinese herb medicines | |
| US20250331548A1 (en) | Heat-not-burn aerosol-generating article, product and manufacturing method thereof | |
| WO2019149257A1 (en) | Aromatic herbal stick for vaporization under heating. | |
| CN108851194A (en) | A kind of honeysuckle health care cigarette and preparation method thereof | |
| CN100574633C (en) | Pomegranate health inhalant and preparation method thereof | |
| Aziz et al. | Pharmacological evaluation of Sedative and Hypnotic activities of methanolic extract of Lycopus europaeus in mice | |
| CN1241502C (en) | Incense rod for refreshment | |
| CN1410015A (en) | Health care cigarette | |
| CN109645549A (en) | cigarette for quitting smoking | |
| JP2959712B2 (en) | Non-smoking smoking article and method for producing the same | |
| WO1999020131A1 (en) | A cigarette of ginkgo leaves | |
| CN103750539A (en) | Inflammation diminishing antibiosis type tobacco nasal cavity spray composition and preparation method thereof | |
| KR19990042936A (en) | Smokers for the treatment of diseases and methods of treating the diseases using the same | |
| CN113398222A (en) | National medicine composition for exorcising evil spirits and preventing epidemic | |
| KR102575957B1 (en) | Cigarette using kenaf and method for manufacturing the same | |
| WO2004068974A1 (en) | A process of preparing a herbal filler composition for bidi cigarette and the like | |
| CN1056227A (en) | Gynostemma medicinal health smoke | |
| CN115721683A (en) | An electronic atomization liquid and its preparation and use method | |
| CN115721685A (en) | Medicinal composition and application of pilea asteroides | |
| KR19990083879A (en) | Manufacturing method of product made out of chief materials of perilla frutescens in replace of smoking | |
| CN117598519B (en) | Electronic cigarette liquid with fresh snail flavor and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 20020511 |